Breast cancer researchers call for ethnicity to be taken into account
when developing treatments.

Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's Lancet (18 July) by researchers from Imperial College London.

A new study in the Journal of Communication reveals that access to an integrated system of internet health resources helps patients more than simply providing a list of URLs to accredited sites.

A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor’s growth and spread, according to a new study from the University of Michigan Comprehensive Cancer Center.

Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show.

Women who took raloxifene were less likely to develop invasive estrogen-receptor (ER) positive breast cancer compared with women who did not, according to data from a randomized controlled trial published online June 10 in the Journal of the National Cancer Institute. The drug did not reduce the risk of non-invasive cancer or invasive ER-negative cancers.

Jayant Vaidya, an Indian surgeon born in Goa, researching and teaching at the Dundee University in Scotland has pioneered a new method for the early detection of breast cancer.

A recent study shows that pre-operative assessments of patients with breast cancer by physical therapists allow for early diagnosis and successful treatment of lymphedema.

A poster session presented today by The University of Texas M. D. Anderson Cancer Center at the Oncology Nurses Society 33rd Annual Congress, found that early nursing intervention and implementation of effective strategies can lead to a decrease in the incidence of lymphedema, better management of chronic lymphedema and improved quality of life in breast cancer patients.

Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center.

Maintaining bone density could be a key to decreasing the spread of cancer in women with locally advanced breast cancer, according to research at Washington University School of Medicine in St. Louis.

A new study of breast cancer survival and Vitamin D by the American Society of Clinical Oncology, finds a link between a deficiency in Vitamin D at the time of diagnosis and the likelihood of their breast cancer metastasizing.